Randomized, double-blind, placebo-controlled trial of the safety and efficacy of MP03-36 in subjects with seasonal allergic rhinitis

Trial Profile

Randomized, double-blind, placebo-controlled trial of the safety and efficacy of MP03-36 in subjects with seasonal allergic rhinitis

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Apr 2015

At a glance

  • Drugs Azelastine (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors Meda Pharmaceuticals
  • Most Recent Events

    • 16 Nov 2010 Results were presented at the 2010 Annual Meeting of the American College of Allergy, Asthma and Immunology.
    • 01 Oct 2009 Results reported in the Allergy and Asthma Proceedings.
    • 17 Mar 2009 Results presented at AAAAI
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top